TAXONOMY PATHWAYS

taXonomy Pathways combines closed claims with labs, EHR, including clinician notes, to deliver a comprehensive view of obesity and GLP‑1 therapies. Our metabolic cohort includes:

• 
  Closed claims: 39.4 M patients with obesity or type 2 diabetes
• 
  Pharmacy claims: 35.2 M patients (≈ 89 %)
• 
  EHR data: 16.7 M patients (≈ 42 %) with weight, BMI and blood‑pressure measures
• 
  Lab data: 29.1 M patients (≈ 74 %) with HbA1c and metabolic panels

Fill out the form to schedule a meeting and explore our metabolic dataset.